ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Editorial
Treatment for COVID-19: How far have we Reached?
DOI: 10.35248/0975-0851.20.12.400
SARS-CoV-2 and the Ongoing Clinical Trials
DOI: 10.35248/0975-0851.20.12.399
COVID-19 in Children, Pregnancy and Neonates
DOI: 10.35248/0975-0851.20.12.398
Editorial Note
Editorial Note for Journal of Bioequivalence & Bioavailability
DOI: 10.35248/0975-0851.20.12.397
Research Article
Model-Based Elaboration of a Limited Sampling Strategy in the Bioequivalence Assessment of Highly Variable Dabigatran
DOI: 10.35248/0975-0851.20.12.396